Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma

Aurobindo Pharma

BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 06, 15:43
445.65
-3.6 (-0.8%)
VOLUME 54,949
LIVE
NSE
Dec 06, 15:57
445.70
-3.45 (-0.77%)
VOLUME 2,307,385
News on Aurobindo Pharma
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Aurobindo Pharma share price up 2% on assets acquisition of US firm

10.15 am | 29 Nov 2019 |  Source: Moneycontrol.com

The assets acquisition is for upfront cash consideration of $11.29 million....

Early on D-Street | Overall trend remains positive, but some profit-booking likely

8.06 am | 29 Nov 2019 |  Source: Moneycontrol.com

FPIs were net buyers in Indian markets for Rs 1,008.89 crore while the DIIs were net sellers to the tune of Rs 155.47 crore, provisional data showed....

Stocks in the news: HDFC Bank, Aurobindo, CG Power, Ashoka Buildcon, Khadim India

7.37 am | 29 Nov 2019 |  Source: Moneycontrol.com

CG Power | Ashoka Buildcon | Hinduja Global Solutions | Khadim India | HDFC Bank and Aurobindo Pharma are stocks which are in the news today....

Aurobindo Pharma to acquire certain biz assets of Profectus BioSciences

7.58 pm | 28 Nov 2019 |  Source: PTI

The acqusition provides access to proprietary and innovative technology platforms for prophylactic use and therapeutic use along with global R&D cente...

Raining USFDA warning letters to Indian drug sites point to intensified regulatory risk

8.55 pm | 25 Nov 2019 |  Source: Moneycontrol.com

Around 18 pharma companies had received USFDA warning letters for their Indian plants in 2019 alone, these were more than half of the all the warning ...

Aurobindo Pharma aims to become debt free in 3 years sans Sandoz deal

11.59 am | 24 Nov 2019 |  Source: PTI

In September last year, the USD three billion drug maker said its US subsidiary entered into an agreement to acquire commercial operations and three m...

Hold Aurobindo Pharma; target of Rs 511: Prabhudas Lilladher

3.57 pm | 20 Nov 2019 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended Hold rating on Aurobindo Pharma with a target price of Rs 511 in its research report dated November 13, 2019....

Hold Aurobindo Pharma target of Rs 500: Sharekhan

11.43 am | 14 Nov 2019 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated November 13, 2019....

Aurobindo Pharma share price hits over 5-yr low on USFDA observations

11.08 am | 14 Nov 2019 |  Source: Moneycontrol.com

Company believes that none of these observations are related to data integrity issues....

Expect FTC nod for $900 million Sandoz deal before December: Aurobindo Pharma

8.10 pm | 13 Nov 2019 |  Source: Moneycontrol.com

The company had announced the acquisition of Sandoz's dermatology and formulations business in September last year, making it the largest outbound...

Aurobindo Pharm Consolidated September 2019 Net Sales at Rs 5,600.47 crore, up 17.87% Y-o-Y

10.01 am | 13 Nov 2019 |  Source: Moneycontrol.com

NULL...

Aurobindo Pharma Q2 net profit grows 4.6% to Rs 639.5 crore

7.15 pm | 12 Nov 2019 |  Source: Moneycontrol.com

Revenues from operation grew by nearly 18 per cent to Rs 5600.5 crore. It was Rs 4,751.4 crore during the same period last fiscal, a company press rel...

Aurobindo Pharma share price falls 5% after Hyderabad units come under USFDA scanner

10.33 am | 06 Nov 2019 |  Source: Moneycontrol.com

Aurobindo believes that these observations are related to procedural improvements and none of the observations are related to data integrity....

Aurobindo Q2 PAT seen up 6% YoY to Rs. 675.1 cr: Emkay

3.47 pm | 14 Oct 2019 |  Source: Moneycontrol.com

Net Sales are expected to increase by 18.8 percent Y-o-Y (up 3.7 percent Q-o-Q) to Rs. 5,645.7 crore, according to Emkay....

Hold Aurobindo Pharma; target of Rs 710: Sharekhan

5.11 pm | 12 Aug 2019 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 710 in its research report dated August 08, 2019....

Buy Aurobindo Pharma; target of Rs 735: ICICI Direct

4.54 pm | 08 Aug 2019 |  Source: Moneycontrol.com

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 735 in its research report dated August ...

Aurobindo Pharm Consolidated June 2019 Net Sales at Rs 5,444.60 crore, up 28.1% Y-o-Y

2.39 pm | 08 Aug 2019 |  Source: Moneycontrol.com

NULL...

Aurobindo Pharm Standalone June 2019 Net Sales at Rs 3,078.83 crore, up 20.32% Y-o-Y

2.39 pm | 08 Aug 2019 |  Source: Moneycontrol.com

NULL...

Hold Aurobindo Pharma; target of Rs 710: Sharekhan

12.34 pm | 02 Jul 2019 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 710 in its research report dated June 28, 2019....

Buy Aurobindo Pharma; target of Rs 800: HDFC Securities

2.35 pm | 06 Jun 2019 |  Source: Moneycontrol.com

HDFC Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 800 in its research report dated May ...

1 2
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.